These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 28906444

  • 1. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
    Brandt A, Jin CJ, Nolte K, Sellmann C, Engstler AJ, Bergheim I.
    Nutrients; 2017 Sep 14; 9(9):. PubMed ID: 28906444
    [Abstract] [Full Text] [Related]

  • 2. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine.
    Brandt A, Hernández-Arriaga A, Kehm R, Sánchez V, Jin CJ, Nier A, Baumann A, Camarinha-Silva A, Bergheim I.
    Sci Rep; 2019 Apr 30; 9(1):6668. PubMed ID: 31040374
    [Abstract] [Full Text] [Related]

  • 3. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.
    Brandt A, Nier A, Jin CJ, Baumann A, Jung F, Ribas V, García-Ruiz C, Fernández-Checa JC, Bergheim I.
    Redox Biol; 2019 Feb 30; 21():101092. PubMed ID: 30605883
    [Abstract] [Full Text] [Related]

  • 4. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
    Baumann A, Jin CJ, Brandt A, Sellmann C, Nier A, Burkard M, Venturelli S, Bergheim I.
    Nutrients; 2020 Mar 30; 12(4):. PubMed ID: 32235497
    [Abstract] [Full Text] [Related]

  • 5. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
    Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I.
    Hepatology; 2009 Oct 30; 50(4):1094-104. PubMed ID: 19637282
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
    Sellmann C, Jin CJ, Engstler AJ, De Bandt JP, Bergheim I.
    Eur J Nutr; 2017 Dec 30; 56(8):2519-2527. PubMed ID: 27496089
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibiotics attenuate diet-induced nonalcoholic fatty liver disease without altering intestinal barrier dysfunction.
    Brandt A, Csarmann K, Hernández-Arriaga A, Baumann A, Staltner R, Halilbasic E, Trauner M, Camarinha-Silva A, Bergheim I.
    J Nutr Biochem; 2024 Jan 30; 123():109495. PubMed ID: 37871765
    [Abstract] [Full Text] [Related]

  • 12. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
    Schumacher-Petersen C, Christoffersen BØ, Kirk RK, Ludvigsen TP, Zois NE, Pedersen HD, Vyberg M, Olsen LH.
    J Transl Med; 2019 Apr 03; 17(1):110. PubMed ID: 30943987
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.
    Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC.
    J Hepatol; 2008 Jun 03; 48(6):983-92. PubMed ID: 18395289
    [Abstract] [Full Text] [Related]

  • 17. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.
    Basciano H, Miller AE, Naples M, Baker C, Kohen R, Xu E, Su Q, Allister EM, Wheeler MB, Adeli K.
    Am J Physiol Endocrinol Metab; 2009 Aug 03; 297(2):E462-73. PubMed ID: 19509184
    [Abstract] [Full Text] [Related]

  • 18. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
    Sellmann C, Baumann A, Brandt A, Jin CJ, Nier A, Bergheim I.
    J Nutr; 2017 Nov 03; 147(11):2041-2049. PubMed ID: 28931589
    [Abstract] [Full Text] [Related]

  • 19. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.
    Baumann A, Burger K, Brandt A, Staltner R, Jung F, Rajcic D, Lorenzo Pisarello MJ, Bergheim I.
    Metabolism; 2022 Aug 03; 133():155233. PubMed ID: 35654114
    [Abstract] [Full Text] [Related]

  • 20. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
    Rahman K, Desai C, Iyer SS, Thorn NE, Kumar P, Liu Y, Smith T, Neish AS, Li H, Tan S, Wu P, Liu X, Yu Y, Farris AB, Nusrat A, Parkos CA, Anania FA.
    Gastroenterology; 2016 Oct 03; 151(4):733-746.e12. PubMed ID: 27342212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.